| P50 | author | Aaron Barchowsky | Q63214710 |
| P2093 | author name string | Yu Chen | |
| | Sanjay Srivastava | |
| | J Christopher States | |
| P2860 | cites work | Arsenic and atherosclerosis | Q23919496 |
| | Arsenic exposure accelerates atherogenesis in apolipoprotein E-/-mice | Q23919503 |
| | Cdc42 regulates arsenic-induced NADPH oxidase activation and cell migration through actin filament reorganization | Q23923986 |
| | The oxidative stressor arsenite activates vascular endothelial growth factor mRNA transcription by an ATF4-dependent mechanism | Q24298728 |
| | Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan | Q24658421 |
| | Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis | Q24676299 |
| | Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh | Q24811655 |
| | The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update | Q24812468 |
| | Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. | Q24815894 |
| | Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure | Q25256866 |
| | Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes | Q28241500 |
| | Do we need genomic research for the prevention of common diseases with environmental causes? | Q28245995 |
| | Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells | Q28360926 |
| | NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells | Q28373343 |
| | Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers | Q28382770 |
| | Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice | Q28382772 |
| | Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. | Q51033915 |
| | Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. | Q51171589 |
| | Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. | Q53338397 |
| | Dimethylarsinic acid effects on DNA damage and oxidative stress related biochemical parameters in B6C3F1 mice. | Q53421815 |
| | Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. | Q53426769 |
| | Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. | Q53596779 |
| | Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study | Q57829475 |
| | Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh | Q57937126 |
| | Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan | Q59277494 |
| | Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer | Q59277526 |
| | Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan | Q59277528 |
| | Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects | Q69403234 |
| | Systemic arterial disease with myocardial infarction. Report on two infants | Q69474638 |
| | Systemic arterial disease and chronic arsenicism in infants | Q69757847 |
| | Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species | Q71758648 |
| | Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a) | Q72100957 |
| | Increased prevalence of hypertension and long-term arsenic exposure | Q72511533 |
| | Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 |
| | Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan | Q79437640 |
| | Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation | Q80795162 |
| | Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water | Q80930485 |
| | Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study | Q81441440 |
| | Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 | Q83161496 |
| | Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease | Q83862815 |
| | Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile | Q28389177 |
| | Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood | Q28390288 |
| | In utero arsenic exposure induces early onset of atherosclerosis in ApoE-/- mice | Q28396600 |
| | C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 |
| | The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance | Q29616511 |
| | Hepatic damage caused by chronic arsenic toxicity in experimental animals | Q31423066 |
| | LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis | Q31807216 |
| | Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells | Q31834318 |
| | A proteome analysis of the arsenite response in cultured lung cells: evidence for in vitro oxidative stress-induced apoptosis | Q33203379 |
| | Redox signaling, vascular function, and hypertension | Q33689229 |
| | Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. | Q33750086 |
| | Low density lipoprotein undergoes oxidative modification in vivo | Q33838672 |
| | Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites | Q33943279 |
| | Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure | Q34068140 |
| | Role of metabolism in arsenic toxicity | Q34085794 |
| | Pulse pressure--a review of mechanisms and clinical relevance | Q34192259 |
| | Folate, vitamin B12 and vitamin B6 and one carbon metabolism | Q34507048 |
| | Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. | Q35011142 |
| | Drinking water arsenic in Utah: A cohort mortality study | Q35029875 |
| | Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids | Q35036420 |
| | Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases | Q35149554 |
| | Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver | Q35575155 |
| | Inflammation as a cardiovascular risk factor | Q35789860 |
| | Role of endothelial dysfunction in atherosclerosis | Q35806066 |
| | Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. | Q35831223 |
| | The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds | Q35846861 |
| | Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study | Q35918665 |
| | Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules | Q36064959 |
| | Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence | Q36306130 |
| | Aldose reductase-catalyzed reduction of aldehyde phospholipids | Q36330024 |
| | The Rac and Rho hall of fame: a decade of hypertrophic signaling hits | Q36436389 |
| | Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart | Q36466156 |
| | Canalization of development by microRNAs | Q36493258 |
| | Modulation of vascular smooth muscle signaling by reactive oxygen species | Q36547056 |
| | Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis | Q36661322 |
| | Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens | Q36709606 |
| | Cytokines and chronic liver disease | Q36745906 |
| | A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases | Q36791196 |
| | Arsenic trioxide initiates ER stress responses, perturbs calcium signalling and promotes apoptosis in human lens epithelial cells. | Q39819063 |
| | Endothelial glutathione-S-transferase A4-4 protects against oxidative stress and modulates iNOS expression through NF-kappaB translocation | Q39981459 |
| | Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study | Q40260941 |
| | Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia | Q40357982 |
| | Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required | Q40552078 |
| | Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. | Q40595070 |
| | Circulating cell adhesion molecules and death in patients with coronary artery disease | Q40686123 |
| | Structural and kinetic determinants of aldehyde reduction by aldose reductase | Q40828650 |
| | Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. | Q40872170 |
| | Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study | Q40873641 |
| | Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis | Q41003504 |
| | Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal | Q42120935 |
| | Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide | Q42138775 |
| | Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis | Q42172013 |
| | Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite | Q42482533 |
| | Hypertension and arsenic exposure in Bangladesh | Q42536337 |
| | Glutathione plays different roles in the induction of the cytotoxic effects of inorganic and organic arsenic compounds in cultured BALB/c 3T3 cells | Q42801644 |
| | Arsenic methylation and bladder cancer risk in Taiwan | Q43516390 |
| | Arsenic and liver disease. | Q43778108 |
| | Biological gradient between long-term arsenic exposure and carotid atherosclerosis | Q43961156 |
| | Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. | Q43963146 |
| | Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China | Q44035402 |
| | Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. | Q44248044 |
| | DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species | Q44249156 |
| | Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice | Q44313185 |
| | Endothelial dysfunction and inflammation in asymptomatic proteinuria. | Q44358537 |
| | Arsenic methylation and skin cancer risk in southwestern Taiwan | Q44379605 |
| | Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. | Q44527604 |
| | Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero | Q44802943 |
| | Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. | Q45158735 |
| | Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells | Q45249917 |
| | Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. | Q45934117 |
| | Arsenic methylation capacity and skin cancer. | Q45973504 |
| | Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice | Q46421418 |
| | Effect of chronic intake of arsenic-contaminated water on liver | Q46556903 |
| | Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States | Q46619067 |
| | Genetic polymorphisms of oxidative and antioxidant enzymes and arsenic-related hypertension | Q46632119 |
| | Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study | Q46774699 |
| | Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation | Q46825449 |
| | Risk of carotid atherosclerosis associated with genetic polymorphisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan. | Q46893743 |
| | Overproduction of large VLDL particles is driven by increased liver fat content in man. | Q46931621 |
| | Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis | Q47788311 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| | arsenic | Q871 |
| P304 | page(s) | 312-23 | |
| P577 | publication date | 2009-02-01 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | Arsenic and cardiovascular disease | |
| P478 | volume | 107 | |